Lurbinectedin Plus Paclitaxel Versus Paclitaxel in Patients With Previously Treated Small Cell Lung Cancer

NCT07640932 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

69

Enrollment

OTHER

Sponsor class

Conditions

Carcinoma, Small Cell Lung

Interventions

DRUG: Lurbinectedin
DRUG: Paclitaxel

Sponsor

Yonsei University